Scottsdale, AZ
Peptide Therapy clinics in Scottsdale
Scottsdale has one of the country's most saturated longevity and aesthetic medicine markets, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Old Town, North Scottsdale, DC Ranch, and Paradise Valley range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Mayo Clinic Scottsdale, HonorHealth, and Banner network. The scene here skews toward Mayo-trained physicians running longevity and peptide clinics alongside medspas. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Scottsdale clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Ziva Wellness MD
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Rejuvenate Hormone and Weight Loss Center
- Vitamin IV Therapy
- PRP Therapy
- IV Hydration
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
ReGen Pain & Wellness
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
- IV Therapy
Prime Body
- PRP Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
HumanBlu
- Biofeedback Therapy
- Shockwave Therapy
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
Mitogenesis Regenerative Medicine
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
Valley Spinal Care
- Ozone Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Bloom Wellness Clinics
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
Viva IV Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Migraine Treatment
Dr. Vanessa Mack
- Vitamin IV Therapy
- IV Therapy
- Peptide Therapy
- Red Light Therapy
- Erectile Dysfunction (ED) Treatment
Sunridge Medical Center
- PRP Therapy
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Hyperbaric Oxygen Therapy (HBOT)
Stem Cell Therapy Professionals
- PRP Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
Natural Radiance Med Spa
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- Red Light Therapy
- Peptide Therapy
Regulatory context
A note on Arizona's peptide therapy rules.
Most research peptides sold in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin are FDA-approved for specific indications. In 2023 and 2024, the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which effectively restricts 503A compounding pharmacies from sourcing those ingredients. Section 503A governs traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP standards.
-
Arizona Revised Statutes Title 32 Chapter 18 (Pharmacy)
Governs compounding, pharmacy licensure, and drug distribution under the Arizona State Board of Pharmacy. -
Arizona Revised Statutes Title 32 Chapter 14 (Naturopathic Physicians)
Grants licensed naturopathic physicians prescriptive authority, including for compounded preparations within scope. -
Arizona Revised Statutes Title 32 Chapter 13 (Medicine and Surgery)
Regulates MD practice and delegation of peptide administration to qualified staff.
The Arizona State Board of Pharmacy inspects compounding facilities under USP 795 (non-sterile) and USP 797 (sterile) standards. The Board has issued disciplinary actions against pharmacies for sourcing non-compliant bulk ingredients and for sterile compounding deficiencies. Non-resident pharmacies shipping peptides into Arizona must hold a non-resident permit. Clinics sourcing from pharmacies outside the state should verify the pharmacy holds a current Arizona non-resident license.